Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its BrainSense adaptive deep brain stimulation ...

Medtronic had to overcome a major supplier glitch in its latest quarter as it tried to keep pace with other large medical-technology companies racing to commercialize new catheter technology that ...

Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues, despite underperformance over the past 7 months. The company posted solid Q2 ...

Looking at the universe of stocks we cover at Dividend Channel, on 12/27/24, Medtronic PLC (Symbol: MDT), DENTSPLY SIRONA Inc (Symbol: XRAY), and Danaher Corp (Symbol: DHR) will all trade ex ...

JAN 6, 2025 – Medtronic plc, a global leader in healthcare technology, today announced it received CE (Conformité Européenne) Mark for the Harmony™ Transcatheter Pulmonary Valve (TPV) System, a ...

Boston Scientific introduced 3 advanced balloon catheters in 2023 for lesion-specific treatment protocols in select Asia-Pacific markets. Medtronic reported developing 2 integrated balloon ...

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...